ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Gregory Curt Nominated DCT Deputy DCC Seeks Occupational Cancer, Prevention Branch Chiefs

October 26, 1984

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

ASCO Foundation Raised $200,000 In Its First Year.

June 2, 2000

NCI Programs: Report Calls for Expansion of Colorectal Cancer Research

April 28, 2000

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985